Showing results (261-270 of 444) with videos related to

Sort By:
Pageof 45
BMJ Open Respiratory Research|March 26, 2015
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacyGiacomo Sgalla, Stefania Cerri, Roberto Ferrari, et al.
Chest|February 23, 2017
Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity PneumonitisPing Wang, Kirk D Jones, Anatoly Urisman, et al.
Chest|June 11, 2019
Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary FibrosisGabrielle Y Liu, Iazsmin Bauer Ventura, Natalia Achtar-Zadeh, et al.
Thorax|October 11, 2017
Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extensionLuca Richeldi, Michael Kreuter, Moisés Selman, et al.
American Journal of Clinical Pathology|November 21, 2008
Eosinophilic globules in bronchoalveolar lavage fluid of patients with systemic sclerosis-related interstitial lung disease: a diagnostically useful, previously unreported finding in a retrospective and prospective study, including differential diagnosis with other idiopathic and secondary interstitial lung diseasesGiulio Rossi, Alessandro Andreani, Paola Morandi, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|April 1, 2024
Dysregulated bidirectional epithelial-mesenchymal crosstalk: a core determinant of lung fibrosis progressionLiudi Yao, Zijian Xu, Donna E Davies, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2016
Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic CriteriaGanesh Raghu, Athol U Wells, Andrew G Nicholson, et al.
The European Respiratory Journal|November 17, 2018
No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidoneLuca Richeldi, Sophie Fletcher, Huzaifa Adamali, et al.
Histopathology|March 8, 2012
Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosisSeung-Ick Cha, Christine S Chang, Eun Kyung Kim, et al.
Transplantation|April 3, 2013
Outcomes in systemic sclerosis-related lung disease after lung transplantationPeter D Sottile, David Iturbe, Tamiko R Katsumoto, et al.
Pageof 45